VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady Solventum SOLV Q1 2026 Earnings EPS Beats Estimates by 734 Revenue Details Unreported Genpact Q1 2026 Earnings EPS Beats Estimates by 424 Stock Edges Lower Envoy Medical Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines BUSEP Q1 2026 Earnings 132 EPS Surprise Boosted by Solid Core Operations